Skip to main navigation Skip to search Skip to main content

A Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date08/6/25 → 08/5/27

Funding

  • CG Oncology: $83,642.70